Good morning, and welcome to the Zurn Elkay Water Solutions Corporation fourth quarter 2022 earnings results conference call with Todd Adams, Chairman and Chief Executive Officer, Mark Peterson, Senior Vice President and Chief Financial Officer, and Dave Pauli, Vice President of Investor Relations for Zurn Elkay Water Solutions. This call is being recorded and will be available for one week. The phone numbers for the replay can be found in the earnings release the company filed in an 8-K with the SEC yesterday, February 7th. At this time, for opening remarks and introduction, I'll turn the call over to Dave Pauli.
Good morning, everyone, and thanks for joining us on the call today. Before we begin, I would like to remind everyone that this call contains certain forward-looking statements that are subject to the safe harbor language contained in the press release that we issued yesterday afternoon, as well as in our filings with the SEC. In addition, some comparisons will refer to non-GAAP measures. Our earnings release and SEC filings contain additional information about these non-GAAP measures, why we use them, and why we believe they're helpful to investors, and contain certain reconciliations to the corresponding GAAP information. Consistent with prior quarters, we will speak to certain non-GAAP metrics as we feel they provide a better understanding of our operating results. These measures are not a substitute for GAAP, and we encourage you to review the GAAP information in our earnings release and in our SEC filings.
With that, I'll turn the call over to Todd Adams, Chairman and CEO of Zurn Elkay Water Solutions.
Thanks, Dave. Good morning, everyone. This is what we hope is a relatively straightforward call. We'll take everyone through what we saw in the fourth quarter, along with some even more recent trends. We'll also lay out what we believe next year could look like, which is broadly reflected in the current consensus. Then we'll get back to work and execute to maximize what we're actually holding ourselves accountable to. After a couple of years of big transformative transactions to completely change our business to a premier pure-play water business, this upcoming year is simply about executing on what's right in front of us. We really like our hand.
It's also not lost on us, the noise of the past few quarters is not what investors expect of us, and realize the only way to do something about it is to execute at a high level, and so that's what we're going to go do. There were a lot of facets to 2022, including some real challenges and some more perception-based. The good news is that over the past six months, we've acted quickly, got to the core of what the new Zurn Elkay is and can be, and the overall cadence at which we've operated historically is fully embedded across the new Zurn Elkay to start 2023, just six months after the close of the deal.
The third-party rep changes, 80/20 simplification decisions, integration planning, supply chain constraints, and extended lead times are largely all behind us. Now it's about leveraging the Zurn Elkay Business System to drive performance and build upon our competitive advantages. As Mark will discuss, the fourth quarter was impacted by some near-end macro issues, including a weaker residential market and some wholesale inventory destocking that is also now essentially behind us. In what's been a pretty eventful last three years, I think it's important to highlight the strength of the legacy Zurn business, which has grown the top line at a compounded annual growth rate of 14% since 2019. If you could turn to page four. We've just taken our board through our three-year strategic plan.
With that as a backdrop, we decided to take the opportunity to formalize a more comprehensive and balanced capital allocation strategy as we start 2023. It's grounded in the resilience of our business, strong balance sheet, and consistently high free cash flow profile we see over the next several years, and our commitment to delivering exceptional shareholder value. Our view of the intrinsic value of the company is materially higher than it sits today, and as a result, we're integrating a significant share repurchase plan into our near to medium-term capital allocation strategy. Our current dividend yield of $0.28 on an annual basis represents a current dividend yield of about 1.3%. We're committed to continually continuing the dividend, and we'll look to review any increases to that annually.
Given the fact that we just increased the dividend in our third quarter, this is something we'll look at over the course of the year and then obviously moving forward. The $500 million buyback represents about 13% of our current market cap and is sized in concert with maintaining a leverage profile between 1x-2x, while also accommodating macro-driven risks in the economy over the next couple of years. For 2023, the minimum repurchase will be $100 million, and it's something that we'll be both programmatic and opportunistic about. M&A has historically been important to us to fill in product categories and enhance our competitive advantages within our portfolio at the bolt-on tuck-in level. The Elkay transaction was transformational and provides us multiple levers to enhance our core growth over time while we continue to cultivate other opportunities.
For this year, think of us as singularly focused on delivering the value we see and saw in the combination with Elkay. The punchline is we believe this formalized, comprehensive approach provides even more leverage to drive shareholder value. As you see in the release, we've already been executing on it across all fronts with $25 million of shares repurchased in the fourth quarter. I'll move on to page five. I touched on our strategic plan just a minute ago, which is our 15th plan since the original Zurn acquisition in 2007. What started as a carve-out diversification play for a private equity-owned multi-industry business and part of the prior Rexnord has now become our core business. We've taken it a step further with the Elkay transaction last year.
As we've developed the now Zurn Elkay Business System, one of the significant pieces of learning and change over time has been the benefit of pure focus. When I say focus, what I really mean is an eighty/twenty focus. In our opinion, spending time, effort, and resources on pieces of our business, whether it's products, customers, channels, where we don't see real strategic upside is pure waste, and it comes at the expense of what really matters. It's that learning that led us to make the decisions on portions of the Elkay residential sink business since closing. With that behind us, our teams have gone out and executed an integration plan that puts us in a position to deliver at least $50 million of synergies over 2023 and 2024, and that's before we capture the growth benefits of what the new Zurn Elkay can deliver.
The second significant thing to point out in our strategic planning process is the concept of deploying breakthroughs. In this three-year plan, we're over-indexing our strategy deployment process around drinking water, actually safe drinking water, focused on K-12 students and schools, which we believe is worth hundreds of millions of dollars of growth moving forward as the states and legislation are now beginning to take meaningful action to solve the issue. The business model framework we leveraged over time has gone through some modifications, but the critical piece of leveraging ZEBS is unchanged. We start 2023 in a spot that places a premium on execution, I can't thank our team enough for all their hard work this past year, and I know we're gonna do great things in the coming years as we execute like we can.
If you turn to page six, I'll spend just a minute on our drinking water strategy. The reality is, in this country, over half the population drink water from lead service lines. The most vulnerable are kids, with the impact felt not only in places that you've heard of, like Flint, but very, very likely in the schools where you live, your kids, your neighbors, nieces, nephews, or grandchildren go to school. With over 131,000 K-12 schools in the U.S., over 13 million kids went to school last year with elevated lead levels. There is, however, a growing awareness and legislation that's beginning to take shape, and we're investing to make sure that we're the go-to solution to address this incredibly solvable problem.
It starts with having a leading market share and largest installed base of point of use drinking water solutions in Elkay. If you turn to page seven, the inherent competitive advantage we have as a starting point is so important. The competitive moat is large and growing, and one that's been built by Elkay over time. Now it's time to take it to another level in our approach to not only grow the category, but ensuring that the follow-on filtration business model is locked in. The category has changed over time from drinking fountains to now bottle fillers. That was the initial evolution, largely a way to improve hygiene and eliminate plastic waste. We believe the next evolution will be ensuring safe drinking water in public and private spaces with the devices and ensuring that through filtration.
By improving the attachment rate and continuing to grow the installed base, we're confident that filtration can be $100 million of high margin recurring revenue in the coming years as we expand accessibility, provide some subscriptions, and embed some proprietary technology to ensure that we're getting the replacement event. Both the funding and awareness is there, whether it's ESSER funding, Filter First legislation, or simply parents, teachers, community members taking some accountability to solve what, again, is a very solvable problem. This will be our why. Walking the talk not only on being recognized for being an ESG compliant company, but to actually be an ESG company, which is a nice segue to page eight.
To give everyone a sense of the progress we've made in bringing these two businesses together to truly operate as one beginning in 2023, we've already fully aligned Zurn Elkay under a comprehensive and uniform ESG strategy and will issue our first combined report later this month. As a combined organization, we made solid progress in 2022 and are firmly on track with the initial set of ESG targets we announced in our 2021 report. In fact, the combination did not require us to step back from our targets. Instead, we'll be announcing seven new ESG targets in our upcoming report that are aimed at improving supplier diversity, air emissions, waste, plastic bottle elimination, engineering, and research and development spend. These new targets provide additional transparency and accountability.
For the first time, we're aligning our reporting framework with the Task Force on Climate-related Financial Disclosures Framework to guide our climate-related risk strategy and targets. We've leveraged a Zurn Elkay Business System and applied our core values of continuous improvement to advance our sustainability efforts. We continued to reduce our greenhouse gas emissions by completing several electricity and natural gas reduction projects in 2022. We also launched energy audits of key facilities, which will identify significant energy reduction opportunities in our 2024 target. Finally, on page nine, here you'll see just a few of the highlights and statistics of the progress we've made over the last several years. Our customers care about the sustainability of their buildings and retrofit products.
That's why we will soon complete our first product life cycle analysis to document end-to-end environmental impact of our Elkay stainless steel sinks with plans to do more. Creating LCAs alongside Environmental Product Declarations gives our customers additional confidence that Zurn Elkay products will help them achieve their own sustainability goals and earn sustainability certifications like WELL v2 and LEED. We simply believe that doing the right thing, and we're proud of our sustainability efforts, continue to be recognized. For the third consecutive year, Newsweek has named Zurn Elkay one of America's Most Responsible Companies. We're continuing to build on all the work we've done, and including embedding ESG into our strategic planning process efforts and hope that you'll take a look at our report later this month. With that, I'll turn it over to Mark.
Thanks, Todd. Please turn to slide number 10. On a year-over-year basis, our fourth quarter sales increased 46% to $340 million. The recently completed merger with Elkay contributed 50% year-over-year growth, while foreign currency translation reduced sales by 100 basis points from the prior year and core sales declined 300 basis points. Sales to our residential end markets down 30% and sales to our non-residential end markets expanding low single digits versus the prior year fourth quarter. Our fourth quarter sales were impacted by two things. During the quarter, our lead times continued to improve and are back to historical normal levels. That improvement had a near-term impact on order patterns from our channel partners in the quarter as they reacted to our improved lead times.
In addition, our residential end markets were approximately 10 points tougher than we've anticipated heading into the quarter. With respect to Elkay in the quarter, I'll provide some color on fourth quarter update on demand trends and 80/20 product line exits. Our non-residential business, which is comprised of drinking water and commercial sinks, continued to experience low double-digit demand growth on a year-over-year basis. As Todd discussed earlier, we are aggressively investing in our growth initiatives to further accelerate demand for safe drinking water. With respect to residential sinks, we continue to execute on our 80/20 simplification actions in the quarter to exit certain residential commodity, private label, and OEM sink SKUs, and remain on track to our targeted SKU reduction and related profitability improvement.
Our cadence of exits is unchanged from our last earnings call. Just as a reminder, we exited another $20 million in the fourth quarter, bringing the total for the second half of 2022 to $25 million or $100 million on an annualized basis. We will be completing the balance of the exits in the first quarter of 2023, bringing total exits to the annualized $115 million. As you'll see in the next slide, these exits will have a year-over-year sales impact of $90 million for calendar year 2023, and a $28 million year-over-year sales impact in the first quarter of 2023. Turning to profitability, our adjusted EBITDA totaled $65 million in the quarter, and our adjusted EBITDA margin was 19% compared to $45 million and 19.4% in the prior year fourth quarter.
The benefits of price realization and our productivity initiatives on our fourth quarter margin was more than offset by the sell-through of higher cost inventory purchased earlier in the year, investments in our growth and supply chain initiatives, as well as the impact of the Elkay merger. Please turn to slide 11, and I'll touch on some balance sheet and leverage highlights. With respect to our net debt leverage, we ended the quarter with leverage at an all-time low of 1.4x , inclusive of approximately $25 million of cash used to repurchase common stock in the quarter. As Todd highlighted earlier, we intend to utilize a minimum of $100 million of our free cash flow in 2023 to continue to execute our share repurchase plan while targeting a net debt leverage ratio in the 1x-2x range over time.
Please turn to slide 12. I'll cover some of the highlights of our outlook for fiscal year 2023, as well as the first quarter of the year. To help better understand the growth trends in the business in 2023, we have presented Zurn Elkay pro forma 2022 sales for the year and first quarter, which takes reported sales for 2022 plus Elkay sales for the first and second quarters of 2022, less a year-over-year impact of the 80/20 product line exits we have executed. As you see on the slide, that results in a pro forma calendar year 2022 jump off point of $1.49 billion. That is the number we'll be working off of to discuss pro forma core growth in the combined business in 2023.
For 2023, we're taking a view on our external outlook that encompasses a broader range of volatility than we have the past couple of years. For the full year, we are projecting consolidated Zurn Elkay sales in the range of $1.5 billion-$1.55 billion, and our consolidated adjusted EBITDA to range from $325 million-$345 million, resulting in a year-over-year margin expansion of at least 110 basis points up to 170 basis points. On the slide, you can see our assumptions related to sales trends for our non-residential and residential product groups at the low and the high end of the range.
For the first quarter of 2023, we are projecting sales to range from $340 million-$355 million, and our adjusted EBITDA margin to range from 19%-19.5%. With respect to our sales outlook, you can see on the page our assumptions for growth trends in our non-residential and residential product groups, which also incorporates a more cautious approach to buying patterns in the channel given the recent improvement in our lead times. Turning to profitability, our first quarter margin will be temporarily impacted by the sell-through of higher cost inventory purchased in 2022, as well as some accelerated investments, primarily related to our safe drinking water growth initiatives Todd covered earlier in the call.
Partially offset by the benefit of our synergy savings related to the Elkay merger, which is on track to deliver the $25 million in 2023. With respect to margin progression over the course of the year and starting in the second quarter, we will begin to benefit from lower material and transportation costs as well as a sequential step down in the growth investments, resulting in an improving margin profile as the year progresses. Before opening the call for questions, I'll touch on a few additional outlook items on page 13. We anticipate our interest expense to be approximately $11 million in the first quarter and approximately $44 million for the full year. Our non-cash stock comp expense should be about $12 million in the first quarter and approximately $47 million for the full year.
Depreciation and amortization will come in around $23 million in the first quarter and approximately $90 million for the full year. Our tax rate on adjusted pre-tax earnings will be in the range of 27%-28% in the first quarter and a range of 28%-29% for the full year. Finally, diluted shares outstanding will be approximately 180 million in the quarter and for the full year before the impact of share repurchases. We'll now open the call up for questions.
Thank you. If you would like to ask a question, please signal by pressing star one. We will take our first question from Bryan Blair from Oppenheimer. Please go ahead.
Thank you. Good morning, guys.
Morning, Bryan.
Something you could offer a little more color on the impact of destocking in Q4 and perhaps offer your views on channel position in Q1. We know that resi remains, you know, on a downward trajectory for the time being. That's unsurprising. More so curious the, you know, the trends and any insights you can offer on the non-res side and, you know, how we should think about Q1 impact and then, you know, going into the seasonally stronger course.
Yeah, Bryan, it's Todd. I'll start and let Mark will sort of fill in some of the blanks. You know, fundamentally, the order patterns really sort of in the back half of November into December were sort of unprecedented in terms of how weak they were, and a lot of it, you know, materially driven by wholesale inventory destocking as our lead times came down. When we crossed over the year and have gotten through January and sort of most of the first couple of weeks of February, or at least first week of February, it's sort of much better than it has been. I would say, you know, obviously there's not a lot of inventory for non-res products in the channel.
What we saw was maybe a lot less inventory destocking and also a combination of our lead times coming in and being sort of back to normal. Our order patterns really through the first, you know, five or six weeks here have been, I would say, very much, you know, in line with what we would expect to see at this time of year. Then obviously ramps heading into, you know, the busier parts of the middle of the year for us.
Yeah. I think just to put some numbers to the first part of your question, Bryan, if you think about, you know, the outlook that we had, and just use the midpoint as a simple starting point, it'd be fair to say if you look at the delta from there to $340, you know, mid to high single digit $ millions would be coming from the residential decline and the balance that are really coming from the dynamic Todd talked about from the order pattern. That just kind of puts some numbers to what Todd was discussing.
Okay. Appreciate the color. If we think of your, you know, core non-res outlook, you know, growth in the mid-single-digit range, how is your team contemplating the growth trajectory for, you know, your key verticals? You, you know, discussed education specifically in the context of the Elkay opportunity, but, you know, that is your largest end market and, you know, there are, you know, even broader opportunities beyond what was presented there. Funding backdrop seems quite good. You know, any incremental color you can offer on education, then of course healthcare matters quite a bit as well.
Yeah. again, I think, you know, half of our non-res is, are those two verticals, which as you point out, continue to be quite good. I think the initial framework, you know, that we've laid out, certainly hedges all of that that growth to get to the range that, you know, we're sort of talking about in that mid-single digits range. You know, I think we're gonna take a intentionally cautious view to start 2023, but I think qualitatively from an end market standpoint, those two are actually still quite good. Obviously, you know, with the drinking water opportunity we see in schools and the way we're investing, we certainly hope to do better than that. I would just.
I would characterize it as sort of a cautious way to start the year and, you know, with a variety of outcomes that are gonna play themselves out over the next 11 months, but I think we feel really good about, you know, those two verticals in particular.
That makes sense. One last one if I may. Thinking about the 2023 EBITDA guidance, maybe walk us through the bridge starting with $265 million in 2022. How to think about year-on-year contribution from cores, earn the full year of Elkay contribution, and then layering on deal synergies? Within that, you know, perhaps how you think of potential risk to the framework, and, you know, also upside to that range?
Sure. you know, I think if you were to pro forma 2022 to include sort of a more full year of Elkay, you really start the year closer to $300. Obviously, we've got $25 million of synergies. you know, if we get some of the growth we expect, you find your way to the higher end of the range. Obviously, as Mark pointed out, you know, we're chewing through some of that high cost inventory to start the year. I think the framework around guidance really puts a premium on just executing at a high level to start the year, work through that high cost inventory, and then, you know, obviously get the synergies from the Elkay transaction that we're highly confident in.
We're starting, you know, the year with the range at $325-$345. I think, you know, we're optimistic that if we execute well and the world sort of hangs together, we've got a chance to clearly end up inside that range at the end of the year, you know, throughout a variety of different scenarios. Rather than try to walk it for you, Bryan, I think that's more the context of how we're thinking about it.
That's understandable. Thanks again, guys.
Next question will come from Jeff Hammond with KeyBanc Capital Markets. Please go ahead.
Hey, good morning, everyone.
Morning, Jeff. Morning, Jeff.
Just wanna go back to the, you know, to the margin ramp. One, can you just talk about, you know, how much of this accelerated investment, you know, falls into Q1? Then just maybe talk through a little bit more the, you know, the higher cost materials. 'Cause it seems like, you know, you guys have been pushing price and staying ahead and now it seems like, you know, you're kinda, you know, maybe having a price cost issue in Q1 . Then just the cadence of the synergies. Thanks.
Jeff, to start with the high cost inventory, I think it's been... You know, when we fought over the course of the year, and it just really gets back to the same phenomenon with the fact that, you know, price, yes, is covering the higher inventory cost, but it's adversely impacting margins as we've not been generating, you know, a normal incremental margin on those price dollars. I think it kind of, you know, came to a head in the fourth quarter and into the first quarter, you know. I think we're at the point where we're still covering the cost, but the margin pressure is just peaking at this point in time. I think as Todd mentioned, look, we feel good about working through that, you know, during the second quarter.
Part of the margin progression over the balance of the year is, you know, that finding its way to more of a, let's say a normalized incremental margin on the price and then getting some benefit in the back half of the year as the price we put in place last year sticks, and you start getting the full benefit of, you know, the improved transportation costs and in the commodity environment. As far as investment goes, again, H1 weighted, given some things we're trying to get in front of, around safe drinking water, marketing campaigns, getting pretty aggressive with that early in the year.
So think about that as something that we're gonna be, again, weighted heavier in the first half and in Q1 probably being the heaviest overweight quarter of all of them. That'll slowly, you know, reduce as the year progresses. Elkay synergies, you know, think about it relatively flat over the course or I should say consistent over the course. Think about $25 million. We'll start with that, you know, $6-ish million in Q1. There's a couple things we've got to get done yet this quarter, but then kind of getting back to that, you know, a little over $6 million cadence over the balance of the year to equal the $25 million. I think a long-winded answer to your question, but hopefully I covered everything you were trying to touch on.
No, that's very helpful. Then just on kinda some of the non-operating items, can you walk through what's driving the higher tax rate? And the interest rate looks oddly high, you know, for $540 million of debt. Just maybe hit those two items.
Interest, you know, we've just kinda used the forward curve, assume that interest rates stay high for the balance of the year. We're hopefully a little conservative on that, but we're assuming that they stay elevated over the balance of the year using the forward curve for 2023. Tax rate. Tax is really a function of some timing of a compensation that ties into this Section 162(m) adjustment. It's effectively a fixed tax item that this year just increases for us for numerous reasons. It's not a variable element that we have to deal with.
I also say, too, Jeff, in our tax rate, you know, we don't assume any equity exercises of the year to the extent there are equity exercises that would drive the rate down as people exercise any form of equity. We assume that doesn't happen in our base rate. Hopefully there's a chance to do a little bit better than that over the course of the year.
Okay. Thanks, guys.
Our next question will come from Mike Halloran with Baird. Please go ahead.
Good morning, everyone.
Morning. Morning, Mike.
Just wanna make sure I understand the dynamic on how you're thinking about the cadence or the growth cadencing through the year on the non-res. It seems like the first quarter is simply sell out, still strong, but sell in a little softer as the order patterns normalize. Beyond the first quarter, the expectation is to have sell out, sell in, be more aligned and therefore the commentary on the end market strength coming through more fully in your numbers, right? I mean, it's as simple as that.
That's it, Mike.
All right. Good. Mark touched on the growth initiatives, talking about some of the promotional activity. Maybe just highlight some of the other things you guys are working on the growth side of things, on the Elkay piece that you think are gonna gain traction as you work through the area.
Well, I mean, you know, again, I think we're leading with safe drinking water and obviously adjacent to that, filtration. I would say the thrust of what you're gonna hear us talk about, what we're focused on, you know, are really those two things. Obviously, we've got, you know, some other opportunities, particularly around building upgrades at MRO now that we have the entire package between all the hygienic products that we had historically and now pairing that with drinking water and sinks. You know, the way to think about what we're focused on is really that drinking water piece, but also the leverage we're getting out of having this broad portfolio that we have, sort of unrivaled and the ability to specify that, spec it, pull it through.
It's an advantage for building owners. It's been a hit with the wholesale community, and we're really excited about, you know, that first turn of traction we're getting.
Our new, newly instituted third-party rep network that has, you know, relationships and, you know, in territories where we're, you know, we went through a lot of change over the course of the last year. Now, you know, six or seven months in, you know, we're really starting to see the traction of driving change and preference and share opportunities with the new fully constituted portfolio.
Thanks for that. Last one, if I may. The share buyback commentary makes a lot of sense. I just wanna clarify something from your prepared remarks. It sounds like you feel comfortable that given the cash flow situation and the leverage levels on the balance sheet, that you'd be able to do a complement of buyback as well as strategic M&A, and then just flex the buyback piece if the M&A opportunities ramp. Is that a fair thought process?
Yeah. I think the way to think about it really, you know, over the course of the... you know, at least as we start the year here is, you know, we set a minimum of $100 million. You know, if you think about the earnings sort of range that we've provided and then the $200 million of cash flow, you can see that you end up in a leverage scenario that is, you know, frankly below where we are today at the end of next year. We do have room to do more on the buyback, and we also have room, you know, to continue to cultivate, you know, some of the bolt-on tuck-in activity that we historically do.
I think that this framework, at least initially, accommodates, you know, sort of a very balanced view of the world with the opportunity to do more on the buyback than clearly the $100 million.
Appreciate it, Todd. Thanks.
Thanks.
Our next question will come from Joe Ritchie with Goldman Sachs. Please go ahead.
Thanks. Good morning. This is Vivek Srivastava on for Joe Ritchie.
Okay.
My first question is just on the residential side. Now that you are exiting the residential sink business on Elkay, can you help us understand how much residential exposure is left in Elkay? On the Zurn side, given the demand for residential is lower this year, help us understand how you're managing factories throughput in this demand environment.
Sure. I mean, Vivek, we, you know, we really are just one company. We're not gonna talk about it as Zurn or Elkay. It's one company. The residential exposure of the entire company is probably in the 12% range of total sales, maybe 13%, today. All that, you know, sort of non-Elkay branded, home center private label business is the stuff that we've decided to walk away from. If you were to look at how are we managing, you know, the production of that portion of our business, we're managing it, you know, very much like we manage the rest of our business. You know, we have a combination of, you know, third-party suppliers. We do some assembly and test. We do some late point modification.
You know, just like we manage the rest of our business, we're flexing, you know, those product categories, those sells, to meet what we see as the current demand. Nothing different and frankly, you know, just sort of one business in aggregate.
That's helpful. Thanks. Then maybe just zooming in within the non-residential vertical, how much office exposure do you guys have? You know, the demand for, there's like, in the office vertical, there's lower build rate and occupancy. Any concerns on demand this year on the office side?
Yeah. I mean, I don't think there's a specific call out there. I mean, if half of the business is institutional, there's a sliver of office. I don't think that there's anything that I could sort of give you qualitatively that makes me excited one way or the other. You know, it's not been a big part of our business for really at any point in time. Obviously the, you know, the thematic, no one's ever going to work again, so that part is dead, has sort of played itself through. I'm not sure exactly how to characterize, you know, what you're trying to zoom in on there, but I wouldn't think of it as a significant headwind or frankly tailwind to our business whatsoever.
Thank you. That's helpful.
Our final question will come from Nathan Jones of Stifel. Please go ahead.
Good morning, everyone.
Good morning, Nathan.
I'd like to go back to this safe drinking water for students slide that's up there, and specifically the $2.9 billion TAM that you've put up there. Elkay obviously has a very large market share of what that TAM would be. Can you talk about, you know, over what kind of time period you would be looking to address that opportunity? How much of that you think will actually be realized? I mean, $2.9 billion with Elkay's market share would be extremely needle moving for the company. Just any more color you can give us around that.
Nathan, I think it's, you know, it's the realities of having a large aged infrastructure in this country. You know, I think we've been fortunate to develop products that are beginning to replace some of that large aged infrastructure. It's been done at a product level as opposed to, you know, these devices actually provide safe drinking water and in many cases in schools for kids. So I think where we're headed with this is to begin to, you know, again, as Mark said, begin to help shape the narrative around what the opportunity is through some broader awareness. Then obviously bookend that with, you know, providing the right kind of filtration to ensure that, you know, when you drink out of these things, you know that the water is actually safe.
You know, I think we've taken a cut at it, you know, 3 years out, and it's, as we talked about, measured in the hundreds of millions of dollars. We're just gonna continue to sort of go back to work and begin to build this thing out, you know, both on the conversion strategy as well as the filtration strategy. I would say that, you know, we would see it, you know, in the, in the hundreds of millions of dollars over the next, you know, call it three years.
That $2.9 billion would be the opportunity if we kind of redid the 131,000 K-12 schools, and we found somebody to pay for it all.
If as a country and really sorta had a timeline, yeah. That's a conversion that's, you know, over, I wouldn't even beg to guess the number of years, but it's 10+ years. It's a big number, yeah. That.
Okay. Sorry.
Again, as you thought, it should continually be refreshed over time. It's a, it's a TAM that's gonna continue to grow as we install, more units. That's a big number for sure.
Got it. That makes sense. Okay, I'm gonna go back 12 months here to the announcement of the Zurn Elkay deal. The deal deck that day had 2023 EBITDA target of $425 million-$450 million. Obviously, a lot has changed over the last 12 months. Higher rates, worse resi. You've got, you know, this year you've got some price cost stuff in the first quarter. Can you talk about the things that need to happen to get back onto a path to that kind of number, whether they are recovery in end markets, things that you guys need to do internally, or whatever else the contributing factors are to get us back onto a path to that kind of target that was laid out a year ago?
Sure. you know, I think the biggest is obviously the embedded run rate, in 2022 for Elkay, you know, frankly, was behind the curve, and I think it's been a well, well-traveled story, really since, we announced the deal that, you know, the combination of the change, in the rep network and the lead times coming down and a lot of different things created a little bit of a hangover in 2022 that, you know, we're gonna think about 2023 as a really strong down payment on getting that back on track. I can tell you that we feel very good about that.
You know, the residential piece of both our business and the combined business, we certainly didn't have that dialed into what we thought 2023, 2024 could look like back in February of 2022, so that's obviously a piece. I would say the vast majority of things to get us on that trajectory are in our control. There's nothing structural. There's nothing permanently off track. The $50 million of synergies are on track. Obviously, we had a double-digit top line growth plan for Zurn at that point in time. We don't have that today, as we talked about. We've got a more conservative growth rate. I would think about 2023 as sort of a, you know, a strong down payment on getting back on that kind of trajectory.
obviously, a lot of it has to do with, the macro side of life that, you know, is out of our control.
Great. Thanks for taking my questions.
Yep.
That will conclude today's question and answer session. At this time, I'd now like to turn the call back over to Dave Pauli for closing remarks.
Thanks everyone for joining us on the call today. We appreciate your interest in Zurn Elkay. We look forward to providing our next update when we announce our March quarter results in late April. Have a good day, everyone.
That will conclude today's conference. Thank you for your participation, and you may now disconnect.